Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
29.18
-1.38 (-4.52%)
At close: Sep 4, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $10.04 billion as of September 12, 2025. Its market cap has decreased by -6.42% in one year.
Market Cap
10.04B
Enterprise Value
11.30B
Revenue
2.84B
Ranking
n/a
PE Ratio
21.83
Stock Price
$29.18
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 10.04B, an increase of 1,413.66%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 10.04B | 0.57% |
| Dec 30, 2024 | 9.98B | 9.75% |
| Dec 29, 2023 | 9.09B | 46.56% |
| Dec 30, 2022 | 6.20B | 1.41% |
| Dec 30, 2021 | 6.12B | 2.35% |
| Dec 30, 2020 | 5.98B | 22.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.19M |